FindTrial
Sign In

Study To Evaluate Long Term Treatment Effect Of Diapep277® In Patients Who Have Completed Study 901 And Study 910** (Extension To 901)

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01281072
Enrollment
Unknown
Registered
2011-01-21
Start date
Unknown
Completion date
Unknown
Last updated
2011-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Giving a Vaccination in Three Months

Brief summary

Open label study to evaluate long term treatment effect of diapep277.

Interventions

OTHERvaccine

Sponsors

DIABETES UNIT
CollaboratorAMBIG
Hadassah Medical Organization
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years

Inclusion criteria

1\. patient that completed 901 and 910 study.

Exclusion criteria

1\. cpeptide\<0.2

Design outcomes

Primary

MeasureTime frame
c peptide reserve—

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026